Synonyms: GSK-2256098
Compound class:
Synthetic organic
|
|
References |
1. Auger KR , Smitheman KN , Korenchuk S, McHugh C, Kruger R , Van Aller GS , Smallwood A, Gontarek RR, Faitg T , Johnson N. (2012)
387 The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer [Abstract]. European Journal of Cancer, 28 (Supplement 6). |
2. GSK.
Mesothelioma drug slows disease progression in patients with an inactive NF2 gene. Accessed on 18/11/2014. Modified on 18/11/2014. sciencedaily.com, http://www.sciencedaily.com/releases/2012/11/121108181445.htm |
3. Lee BY, Timpson P, Horvath LG, Daly RJ. (2015)
FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther, 146: 132-49. [PMID:25316657] |
4. Schultze A, Fiedler W. (2011)
Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase. Anticancer Agents Med Chem, 11 (7): 593-9. [PMID:21787277] |
5. Zhang J, He DH, Zajac-Kaye M, Hochwald SN. (2014)
A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells. Cell Cycle, 13 (19): 3143-9. [PMID:25486573] |